200 related articles for article (PubMed ID: 33997167)
21. Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5-alpha reductase inhibitor resistance.
Jin R; Forbes CM; Miller NL; Lafin J; Strand DW; Case T; Cates JM; Liu Q; Ramirez-Solano M; Mohler JL; Matusik RJ
Prostate; 2024 Apr; 84(5):441-459. PubMed ID: 38168866
[TBL] [Abstract][Full Text] [Related]
22. Single-cell ATAC-seq of fetal human retina and stem-cell-derived retinal organoids shows changing chromatin landscapes during cell fate acquisition.
Finkbeiner C; Ortuño-Lizarán I; Sridhar A; Hooper M; Petter S; Reh TA
Cell Rep; 2022 Jan; 38(4):110294. PubMed ID: 35081356
[TBL] [Abstract][Full Text] [Related]
23. Genomic and epigenomic active vitamin D responses in human colonic organoids.
Li J; Witonsky D; Sprague E; Alleyne D; Bielski MC; Lawrence KM; Kupfer SS
Physiol Genomics; 2021 Jun; 53(6):235-248. PubMed ID: 33900108
[TBL] [Abstract][Full Text] [Related]
24. Modeling the effect of prolonged ethanol exposure on global gene expression and chromatin accessibility in normal 3D colon organoids.
Devall M; Jennelle LT; Bryant J; Bien S; Peters U; Powell S; Casey G
PLoS One; 2020; 15(1):e0227116. PubMed ID: 31951625
[TBL] [Abstract][Full Text] [Related]
25. Pooled In Vitro and In Vivo CRISPR-Cas9 Screening Identifies Tumor Suppressors in Human Colon Organoids.
Michels BE; Mosa MH; Streibl BI; Zhan T; Menche C; Abou-El-Ardat K; Darvishi T; Członka E; Wagner S; Winter J; Medyouf H; Boutros M; Farin HF
Cell Stem Cell; 2020 May; 26(5):782-792.e7. PubMed ID: 32348727
[TBL] [Abstract][Full Text] [Related]
26. A combined computational and functional approach identifies IGF2BP2 as a driver of chemoresistance in a wide array of pre-clinical models of colorectal cancer.
Kendzia S; Franke S; Kröhler T; Golob-Schwarzl N; Schweiger C; Toeglhofer AM; Skofler C; Uranitsch S; El-Heliebi A; Fuchs J; Punschart A; Stiegler P; Keil M; Hoffmann J; Henderson D; Lehrach H; Yaspo ML; Reinhard C; Schäfer R; Keilholz U; Regenbrecht C; Schicho R; Fickert P; Lax SF; Erdmann F; Schulz MH; Kiemer AK; Haybaeck J; Kessler SM
Mol Cancer; 2023 May; 22(1):89. PubMed ID: 37248468
[TBL] [Abstract][Full Text] [Related]
27. A new pancreatic adenocarcinoma-derived organoid model of acquired chemoresistance to FOLFIRINOX: First insight of the underlying mechanisms.
Hadj Bachir E; Poiraud C; Paget S; Stoup N; El Moghrabi S; Duchêne B; Jouy N; Bongiovanni A; Tardivel M; Weiswald LB; Vandepeutte M; Beugniez C; Escande F; Leteurtre E; ; Poulain L; Lagadec C; Pigny P; Jonckheere N; Renaud F; Truant S; Van Seuningen I; Vincent A
Biol Cell; 2022 Jan; 114(1):32-55. PubMed ID: 34561874
[TBL] [Abstract][Full Text] [Related]
28. CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes.
Takeda H; Kataoka S; Nakayama M; Ali MAE; Oshima H; Yamamoto D; Park JW; Takegami Y; An T; Jenkins NA; Copeland NG; Oshima M
Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15635-15644. PubMed ID: 31300537
[TBL] [Abstract][Full Text] [Related]
29. Integrated Chromatin Accessibility and Transcriptome Landscapes of 5-Fluorouracil-Resistant Colon Cancer Cells.
Zhang B; Lin J; Zhang J; Wang X; Deng X
Front Cell Dev Biol; 2022; 10():838332. PubMed ID: 35252200
[No Abstract] [Full Text] [Related]
30. Integrated multi-omics analyses on patient-derived CRC organoids highlight altered molecular pathways in colorectal cancer progression involving PTEN.
Codrich M; Dalla E; Mio C; Antoniali G; Malfatti MC; Marzinotto S; Pierobon M; Baldelli E; Di Loreto C; Damante G; Terrosu G; Pucillo CEM; Tell G
J Exp Clin Cancer Res; 2021 Jun; 40(1):198. PubMed ID: 34154611
[TBL] [Abstract][Full Text] [Related]
31. Patient-specific modeling of stroma-mediated chemoresistance of pancreatic cancer using a three-dimensional organoid-fibroblast co-culture system.
Schuth S; Le Blanc S; Krieger TG; Jabs J; Schenk M; Giese NA; Büchler MW; Eils R; Conrad C; Strobel O
J Exp Clin Cancer Res; 2022 Oct; 41(1):312. PubMed ID: 36273171
[TBL] [Abstract][Full Text] [Related]
32. Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets.
Tang F; Xu D; Wang S; Wong CK; Martinez-Fundichely A; Lee CJ; Cohen S; Park J; Hill CE; Eng K; Bareja R; Han T; Liu EM; Palladino A; Di W; Gao D; Abida W; Beg S; Puca L; Meneses M; de Stanchina E; Berger MF; Gopalan A; Dow LE; Mosquera JM; Beltran H; Sternberg CN; Chi P; Scher HI; Sboner A; Chen Y; Khurana E
Science; 2022 May; 376(6596):eabe1505. PubMed ID: 35617398
[TBL] [Abstract][Full Text] [Related]
33. Functional genomics analysis of human colon organoids identifies key transcription factors.
Yin S; Ray G; Kerschner JL; Hao S; Perez A; Drumm ML; Browne JA; Leir SH; Longworth M; Harris A
Physiol Genomics; 2020 Jun; 52(6):234-244. PubMed ID: 32390556
[TBL] [Abstract][Full Text] [Related]
34. Transcriptomic Response to Calcium in Normal Colon Organoids is Impacted by Colon Location and Sex.
Devall MAM; Dampier CH; Eaton S; Ali MW; Plummer SJ; Bryant J; Gauderman WJ; Peters U; Powell SM; Casey G
Cancer Prev Res (Phila); 2022 Oct; 15(10):679-688. PubMed ID: 36095330
[TBL] [Abstract][Full Text] [Related]
35. Patient-derived organoids as a preclinical platform for precision medicine in colorectal cancer.
Cho YW; Min DW; Kim HP; An Y; Kim S; Youk J; Chun J; Im JP; Song SH; Ju YS; Han SW; Park KJ; Kim TY
Mol Oncol; 2022 Jun; 16(12):2396-2412. PubMed ID: 34850547
[TBL] [Abstract][Full Text] [Related]
36. Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic Heterogeneity.
Bruun J; Kryeziu K; Eide PW; Moosavi SH; Eilertsen IA; Langerud J; Røsok B; Totland MZ; Brunsell TH; Pellinen T; Saarela J; Bergsland CH; Palmer HG; Brudvik KW; Guren T; Dienstmann R; Guren MG; Nesbakken A; Bjørnbeth BA; Sveen A; Lothe RA
Clin Cancer Res; 2020 Aug; 26(15):4107-4119. PubMed ID: 32299813
[TBL] [Abstract][Full Text] [Related]
37. MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2.
Li P; Zhang X; Wang H; Wang L; Liu T; Du L; Yang Y; Wang C
Mol Cancer Ther; 2017 Apr; 16(4):739-751. PubMed ID: 28069878
[TBL] [Abstract][Full Text] [Related]
38. Modeling of senescence-related chemoresistance in ovarian cancer using data analysis and patient-derived organoids.
Cai X; Li Y; Zheng J; Liu L; Jiao Z; Lin J; Jiang S; Lin X; Sun Y
Front Oncol; 2023; 13():1291559. PubMed ID: 38370348
[TBL] [Abstract][Full Text] [Related]
39. Precision medicine-guided co-delivery of ASPN siRNA and oxaliplatin by nanoparticles to overcome chemoresistance of colorectal cancer.
Huang CZ; Zhou Y; Tong QS; Duan QJ; Zhang Q; Du JZ; Yao XQ
Biomaterials; 2022 Nov; 290():121827. PubMed ID: 36228517
[TBL] [Abstract][Full Text] [Related]
40. Organoids Derived from Neoadjuvant FOLFIRINOX Patients Recapitulate Therapy Resistance in Pancreatic Ductal Adenocarcinoma.
Farshadi EA; Chang J; Sampadi B; Doukas M; Van 't Land F; van der Sijde F; Vietsch EE; Pothof J; Koerkamp BG; van Eijck CHJ
Clin Cancer Res; 2021 Dec; 27(23):6602-6612. PubMed ID: 34580113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
